Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study will compare the safety and efficacy of sunitinib in combination with FOLFOX
versus bevacizumab in combination with FOLFOX for the treatment of patients with metastatic
colorectal cancer who have not been treated before.